This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_MULT_MYELOMA_EXALLC for full statistics.
Multiple myeloma
C3_MULT_MYELOMA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
856 |
4. Check minimum number of eventsNone |
856 |
5. Include endpointsNone |
856 |
6. Filter based on genotype QC (FinnGen only) |
856 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Multiple myeloma
based on the number of shared cases.
Similar with more cases:
- Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)
- Multiple myeloma, excluding all cancers (controls excluding all cancers)
- Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 856 | 375 | 481 |
| Unadjusted period prevalence (%) | 0.18 | 0.13 | 0.21 |
| Median age at first event (years) | 70.29 | 69.23 | 71.12 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 822
- Matched controls
- 8218
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
205.0
323.0
675
180
C90.0
ICD-10 Finland
Multiple myeloma
6684.4
323.0
775
20
L04AX04
ATC
lenalidomide; oral
1883.2
323.0
395
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
+∞
323.0
808
*
153
Kela drug reimbursment
Lenalidomid
1761.5
323.0
428
5
H02AB02
ATC
dexamethasone; systemic
37.0
323.0
560
448
XW000
NOMESCO Finland
Bone marrow biopsy
41.8
318.9
409
190
329
Kela drug reimbursment
Lenalidomide
673.0
256.9
241
5
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
369.9
225.7
218
8
L03AA02
ATC
filgrastim; parenteral
47.1
225.3
276
87
WW300
NOMESCO Finland
Transfer of autologic stem cells
773.5
192.2
182
*
M04AA01
ATC
allopurinol; systemic
10.8
190.1
453
838
AA1AA
NOMESCO Finland
Head X-ray examination
93.1
187.4
204
29
A04AA01
ATC
ondansetron; systemic, rectal
18.5
186.2
308
258
L01AA03
ATC
melphalan; systemic
1090.8
183.8
173
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
17.2
173.7
295
259
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
34.4
149.0
196
74
J05AB01
ATC
aciclovir; systemic
7.8
144.0
426
1001
ZX112
NOMESCO Finland
Subcutaneous
33.3
142.5
189
73
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
220.1
128.7
130
7
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.2
126.9
563
2142
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
22.2
120.9
181
103
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
1293.1
117.8
112
*
N02AA05
ATC
oxycodone; systemic
6.7
115.7
367
886
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
36.1
111.2
144
48
1XX32
NOMESCO Finland
NA
+∞
108.8
102
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
46.0
107.6
132
34
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
19.3
103.9
163
104
M05BA02
ATC
clodronic acid; systemic
82.4
102.5
114
16
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
110.5
98.7
106
11
393
Kela drug reimbursment
Pomalidomide
1058.1
98.1
94
*
J05AB11
ATC
valaciclovir; oral
6.7
94.9
281
590
ZX120
NOMESCO Finland
Intravenous
7.4
92.4
249
456
WW402
NOMESCO Finland
Leucoferesis
+∞
91.4
86
*
1507
Kela drug reimbursment
Pomalidomide
920.1
86.2
83
*
L04AX06
ATC
pomalidomide; oral
920.1
86.2
83
*
B03XA02
ATC
darbepoetin alfa; parenteral
24.5
84.9
122
58
NE1AA
NOMESCO Finland
Pelvis X-ray examination
7.8
84.2
214
354
YNB10
NOMESCO Finland
Collection of stem cells for transplant
286.8
77.9
78
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.7
77.7
181
258
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
6.4
77.6
231
472
R50.9
ICD-10 Finland
Fever, unspecified
5.5
77.0
266
653
WW500
NOMESCO Finland
Blood transfusion
10.4
74.9
155
179
L04AX02
ATC
thalidomide; oral
390.3
72.9
72
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
10.8
72.1
146
161
WF049
NOMESCO Finland
Radiotherapy of metastasis
11.1
69.3
138
147
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.1
67.2
248
642
WW409
NOMESCO Finland
Other aferesis
679.3
64.8
63
*
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
64.4
61
*
B03XA01
ATC
erythropoietin; parenteral
28.9
63.2
86
33
B01AB05
ATC
enoxaparin; parenteral
3.6
62.7
414
1810
ZX108
NOMESCO Finland
Inhalation
48.4
62.0
75
17
WW200
NOMESCO Finland
Immunization
14.9
61.8
106
81
398
Kela drug reimbursment
Ixazomib
319.4
59.1
59
*
5BA08
NOMESCO Finland
NA
60.6
57.6
67
12
1505
Kela drug reimbursment
Ixazomib
295.3
54.9
55
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
19.8
53.1
81
45
212
Kela drug reimbursment
Gout
11.5
52.9
102
100
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.1
51.5
134
218
L01AA01
ATC
cyclophosphamide; systemic
37.1
48.6
62
18
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
14.2
45.6
79
61
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.0
45.5
365
1716
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
+∞
45.2
43
*
M49.5*C90.0
ICD-10 Finland
Vertebral fracture due to multiple myeloma
+∞
43.1
41
*
TK800
NOMESCO Finland
Hemodialysis
13.0
42.7
77
65
D64.9
ICD-10 Finland
Anaemia, unspecified
3.8
40.8
198
630
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
40.3
493
2937
B74
ICPC
Malignant neoplasm blood other
75.3
38.3
43
6
J01MA12
ATC
levofloxacin; systemic
3.1
38.1
263
1087
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.5
36.8
83
107
A02BC02
ATC
pantoprazole; systemic
2.7
36.3
611
4246
L01XX50
ATC
[U] ixazomib; oral
373.0
36.3
36
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.9
36.2
94
150
N17.9
ICD-10 Finland
Acute renal failure, unspecified
6.4
34.7
96
167
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
33.6
32
*
NB6AA
NOMESCO Finland
Humerus X-ray examination
9.8
33.5
69
76
GA5AA
NOMESCO Finland
Rib X-ray examination
30.9
33.3
44
15
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
17.5
32.4
51
31
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.8
32.3
96
183
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
19.2
32.2
49
27
1CX01
NOMESCO Finland
NA
62.6
31.3
36
6
WF004
NOMESCO Finland
Palliative radiotherapy
9.4
31.2
66
76
A06AD11
ATC
lactulose; oral
2.9
30.9
223
928
C03CA01
ATC
furosemide; systemic
2.4
30.1
403
2371
J01MA14
ATC
moxifloxacin; systemic
3.8
29.9
141
429
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
29.8
255
1178
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
24.0
27.6
39
17
C90
ICD-10 Finland
Multiple myeloma and malignant plasma cell neoplasms
279.8
26.9
27
*
5BA03
NOMESCO Finland
NA
+∞
26.2
25
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
16.3
26.1
42
27
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
7.5
25.8
62
88
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.7
24.9
209
936
E83.50
ICD-10 Finland
Hypercalcemia
11.0
24.6
47
45
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
10.6
24.6
48
48
JN4AD
NOMESCO Finland
Body CT examination
3.5
24.1
122
390
1AA01
NOMESCO Finland
NA
246.9
23.8
24
*
C90.1
ICD-10 Finland
Plasma cell leukaemia
246.9
23.8
24
*
N08.1*C90.0
ICD-10 Finland
Glomerular disorders in multiple myeloma
236.3
22.7
23
*
B01AB10
ATC
tinzaparin; parenteral
3.7
22.6
104
307
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
23.0
21.8
31
14
L01XG03
ATC
ixazomib; oral
225.8
21.7
22
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
21.1
159
663
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
17.1
21.1
33
20
N03AX16
ATC
pregabalin; oral
2.3
21.0
237
1230
2030A
ICD-9 Finland
Multiple myeloma and immunoproliferative neoplasms, Multiple myeloma
+∞
20.9
20
*
Z51.5
ICD-10 Finland
Palliative care
3.5
20.9
102
316
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
20.8
294
1689
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
16.3
20.7
33
21
NBJ60
NOMESCO Finland
Internal fixation of fracture of shoulder or upper arm using intramedullary nail, humerus
112.9
20.7
22
*
E85.89
ICD-10 Finland
Other amyloidosis
112.9
20.7
22
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
20.2
217
1096
NF3AA
NOMESCO Finland
Femur X-ray examination
7.1
19.8
49
73
E85.9
ICD-10 Finland
Amyloidosis, unspecified
29.8
19.7
26
9
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
19.4
330
2035
WX1DG
NOMESCO Finland
Very extensive total body MRI with high intensity magnet
+∞
18.8
18
*
H02AB06
ATC
prednisolone; systemic
1.9
18.7
426
2927
WX1BG
NOMESCO Finland
Total body MRI with high intensity magnet
194.2
18.6
19
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
25.7
18.3
25
10
NB4AA
NOMESCO Finland
Scapula X-ray examination
25.7
18.3
25
10
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
10.7
18.3
35
34
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
14.8
18.2
30
21
A41.9
ICD-10 Finland
Sepsis, unspecified
4.3
18.2
69
171
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.7
18.0
132
538
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
97.2
17.6
19
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
11.9
17.1
31
27
N02AX02
ATC
tramadol; systemic, rectal
1.9
17.1
388
2629
3XA02
NOMESCO Finland
NA
92.0
16.6
18
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
9.3
16.5
34
38
127
Kela drug reimbursment
Transplant complication
10.4
16.5
32
32
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.0
16.5
276
1665
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
16.3
117
471
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
30.7
16.2
21
7
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
6.0
15.9
44
77
M36.1*C90.0
ICD-10 Finland
Arthropathy in multiple myeloma
+∞
15.7
15
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.6
15.4
124
533
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.9
15.3
50
107
EBA10
NOMESCO Finland
Surgical removal of tooth
3.1
15.2
88
309
306
Kela drug reimbursment
Erythropoietin and darbepoetin
23.9
15.2
21
9
NA2AD
NOMESCO Finland
Thoracic spine CT examination
20.5
15.2
22
11
H02AB09
ATC
hydrocortisone; systemic
6.7
15.1
38
59
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.9
15.1
96
359
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
15.0
124
541
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.5
14.9
53
124
N17.8
ICD-10 Finland
Other acute renal failure
8.5
14.9
32
39
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
25.6
14.7
20
8
A11CC03
ATC
alfacalcidol; systemic
5.7
14.7
42
77
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.4
14.7
74
235
M49.5
ICD-10 Finland
Collapsed vertebra in diseases classified elsewhere
81.6
14.6
16
*
A05AA02
ATC
ursodeoxycholic acid; oral
10.3
14.5
28
28
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
152.6
14.5
15
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.8
14.4
48
105
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
22.7
14.3
20
9
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
13.9
378
2658
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
8.8
13.8
29
34
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
5.4
13.8
41
79
6BA02
NOMESCO Finland
NA
34.7
13.5
17
5
M05BX04
ATC
denosumab; parenteral
3.1
13.5
78
273
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
5.3
13.5
41
81
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
6.4
13.5
35
57
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
13.2
191
1074
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
17.1
13.0
20
12
SAA03
NOMESCO Finland
Extended examination of mouth
1.8
12.9
269
1726
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.9
12.8
78
283
B02.9
ICD-10 Finland
Zoster without complication
3.0
12.6
74
263
A40.8
ICD-10 Finland
Other streptococcal sepsis
10.3
12.0
23
23
N19
ICD-10 Finland
Unspecified kidney failure
3.4
11.9
58
180
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.9
11.9
73
266
A07AA02
ATC
nystatin; oral
2.8
11.9
77
291
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
7.0
11.7
28
41
M90.7
ICD-10 Finland
Fracture of bone in neoplastic disease
65.9
11.6
13
*
H02AB07
ATC
prednisone; oral
2.1
11.3
144
764
JN4BD
NOMESCO Finland
Extensive body CT
2.2
11.3
124
619
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.7
11.2
48
135
M48.5
ICD-10 Finland
Collapsed vertebra, not elsewhere classified
20.4
11.2
16
8
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.2
11.1
57
185
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
10.7
177
1036
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
21.8
10.7
15
7
L03AB05
ATC
interferon alfa-2b; parenteral
14.4
10.5
17
12
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.7
10.5
45
127
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
111.4
10.4
11
*
N18.8
ICD-10 Finland
Other chronic renal failure
3.8
10.4
43
117
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.4
10.2
49
151
N05CF01
ATC
zopiclone; oral
1.7
10.1
298
2089
SPAT1088
SPAT
Blood transfusion
11.5
10.1
18
16
L04AD01
ATC
ciclosporin; systemic
6.6
10.1
25
39
N05BA06
ATC
lorazepam; systemic, sublingual
2.8
10.1
64
240
L03AA13
ATC
pegfilgrastim; parenteral
3.5
9.9
45
133
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
12.4
9.9
17
14
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
9.9
167
984
R80
ICD-10 Finland
Isolated proteinuria
10.8
9.8
18
17
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
9.8
86
385
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
5.4
9.7
28
53
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
3.5
9.7
44
130
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
55.7
9.7
11
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
9.6
155
898
A79
ICPC
Malignancy NOS
5.2
9.5
28
55
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
7.7
9.5
21
28
N08.1
ICD-10 Finland
Glomerular disorders in neoplastic diseases
+∞
9.4
9
*
1XX45
NOMESCO Finland
NA
+∞
9.4
9
*
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
22.0
9.4
13
6
S42.3
ICD-10 Finland
Fracture of shaft of humerus
7.0
9.4
22
32
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
4.3
9.3
33
79
XX3DW
NOMESCO Finland
Time consuming IT work
2.2
9.3
98
481
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
6.8
9.2
22
33
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
3.7
9.1
38
105
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
9.1
132
733
L71
ICPC
Malignant neoplasm musculoskeletal
37.1
9.0
11
*
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
12.7
8.9
15
12
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.3
8.8
31
74
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
50.5
8.7
10
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
8.6
145
850
R4110
NOMESCO Finland
Physiotherapy
1.7
8.5
223
1501
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.1
8.5
32
81
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.5
8.5
64
265
N16.1*C90.0
ICD-10 Finland
Renal tubulo-interstitial disorders in multiple myeloma
91.0
8.4
9
*
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
8.0
8.4
18
23
NFJ60
NOMESCO Finland
Internal fixation of fracture of other parts of femur with intramedullary nail
8.7
8.3
17
20
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
7.2
8.3
19
27
H02AB04
ATC
methylprednisolone; systemic
1.9
8.1
119
664
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
4.5
8.1
27
61
I43.1*E85.9
ICD-10 Finland
Cardiac amyloidosis
33.7
8.1
10
*
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
13.2
7.9
13
10
GD1AD
NOMESCO Finland
Thorax CT examination
2.8
7.9
50
188
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.8
7.8
49
181
A28
ICPC
Limited function/disability NOS
1.7
7.7
168
1065
N08.4*E85.9
ICD-10 Finland
Glomerular disorders in amyloidosis
45.4
7.7
9
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
45.4
7.7
9
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
5.2
7.6
22
43
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
25.3
7.6
10
*
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
10.2
7.5
14
14
WZC30
NOMESCO Finland
Teaching
1.9
7.5
111
623
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
7.5
199
1339
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
80.8
7.4
8
*
NB4DA
NOMESCO Finland
Bilateral scapula X-ray examination
80.8
7.4
8
*
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.1
7.3
88
454
F43.29
ICD-10 Finland
Adaptation disorder UNS
8.0
7.1
15
19
A98
ICPC
Health maint/preventive medicine
0.6
7.1
575
6443
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
7.0
84
433
A02BC01
ATC
omeprazole; systemic
1.6
7.0
238
1701
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
4.9
6.9
21
44
WF099
NOMESCO Finland
Other radiotherapy
11.0
6.8
12
11
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.0
6.8
36
122
WX892
NOMESCO Finland
Monitored bed care
2.1
6.8
72
355
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.1
6.8
76
383
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
4.4
6.8
23
54
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
16.9
6.8
10
6
L03AA04
ATC
NA
16.9
6.8
10
6
E85.3
ICD-10 Finland
Secondary systemic amyloidosis
22.7
6.7
9
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
6.6
175
1174
H26.3
ICD-10 Finland
Drug-induced cataract
12.4
6.6
11
9
XF600
NOMESCO Finland
Bloodpressure measurement
2.3
6.5
56
251
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
5.1
6.5
19
38
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.4
6.5
29
87
J20.4
ICD-10 Finland
Acute bronchitis due to parainfluenza virus
70.4
6.4
7
*
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
70.4
6.4
7
*
B34.9
ICD-10 Finland
Viral infection, unspecified
4.5
6.4
21
48
RS221
NOMESCO Finland
NA
5.2
6.3
18
35
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
4.6
6.3
20
44
3AA13
NOMESCO Finland
NA
18.2
6.3
9
5
M82.0*C90.0
ICD-10 Finland
Osteoporosis in multiple myelomatosis
+∞
6.3
6
*
20399
ICD-8 Finland
Multiple myeloma
+∞
6.3
6
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
4.8
6.3
19
40
GA6AA
NOMESCO Finland
Sternal X-ray examination
26.9
6.2
8
*
5AB01
NOMESCO Finland
NA
26.9
6.2
8
*
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.1
6.2
65
320
SPAT1255
SPAT
Intravenous administration of medicine
2.1
6.1
65
321
N18.0
ICD-10 Finland
End-stage renal disease
4.7
6.1
19
41
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
3.2
6.1
30
97
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.1
6.0
30
98
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
5.2
6.0
17
33
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.9
6.0
35
126
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
502
876
12.44
317.84
13.3
3.5
226.8
256.5
u/l
2.27
490
823
549
269
55.12
307.65
22.6
2.2
143.8
38.3
mg/l
3.61
504
220
547
263
55.85
307.65
21.8
2.1
41.3
1.4
ratio
1.60
42
27
398
328
21.81
307.65
20.5
1.6
—
—
—
0
0
548
269
54.84
307.65
22.6
2.2
197.2
50.0
mg/l
2.21
504
217
398
328
21.81
307.65
20.5
1.6
7.0
7.6
g/l
3.77
292
236
355
307
19.05
307.65
21.8
1.6
10.7
10.3
g/l
0.35
290
257
402
361
20.11
307.65
4.9
1.8
0.5
1.7
g/l
4.64
319
328
483
453
23.17
307.65
10.6
2.3
13.2
10.7
g/l
3.41
451
411
321
125
40.49
307.65
1.8
1.6
—
—
—
0
0
398
327
21.88
307.65
20.5
1.6
4.1
3.8
g/l
0.37
260
230
563
687
22.02
307.65
23.3
2.1
67.4
66.0
g/l
2.14
549
609
369
303
20.65
307.65
21.4
1.6
2.9
3.2
g/l
4.15
261
234
362
280
21.67
307.65
20.1
1.7
7.0
0.8
g/l
22.66
325
234
266
249
15.05
259.73
23.3
1.4
0.2
0.0
g/l
1.40
253
220
127
10
148.95
254.76
1.2
1.6
—
—
—
0
0
254
262
13.36
231.54
23.8
1.4
37.2
37.0
g/l
0.20
237
219
242
236
13.90
228.73
24.6
1.4
0.0
0.0
g/l
0.50
231
208
237
232
13.74
223.19
25.1
1.4
0.0
0.0
g/l
0.00
231
207
179
106
21.09
222.96
5.3
5.0
228.5
234.3
iu/ml
0.03
42
16
419
961
7.58
193.15
4.9
2.2
1.7
1.8
%
1.21
392
848
434
1032
7.50
192.91
6.8
1.4
3.5
2.7
g/l
1.39
368
586
389
996
6.33
154.90
11.9
4.8
1.1
1.0
mmol/l
3.22
371
902
157
180
10.46
129.58
2.6
1.6
—
—
—
0
0
152
173
10.47
126.02
2.7
1.6
—
—
—
0
0
492
1814
5.03
121.35
11.7
2.7
1902.7
9082.8
umol/l
4.01
477
1519
127
118
12.46
121.08
1.4
1.1
79.0
35.6
u/l
2.47
119
99
110
85
14.70
117.35
2.2
2.5
315.4
619.6
u/ml
—
5
7
103
73
15.90
115.29
2.7
1.7
—
—
—
0
0
103
76
15.27
112.71
2.7
1.7
—
—
—
0
0
122
133
10.53
103.81
2.7
1.7
—
—
—
0
0
95
72
14.72
102.20
1.5
1.3
166.1
118.3
u/ml
—
15
8
245
579
5.53
101.94
2.4
1.6
—
—
—
0
0
74
34
23.73
101.24
1.7
3.0
27.5
39.9
%
1.42
19
13
112
116
10.96
98.74
1.2
1.2
—
—
—
0
0
144
211
8.00
96.57
1.4
1.5
—
—
—
0
0
349
1141
4.48
96.50
7.5
3.1
0.8
0.8
mmol/l
0.81
342
1050
115
129
10.14
95.63
3.7
3.9
2.0
1.1
%
0.80
92
104
92
76
13.44
93.94
1.6
1.1
—
—
—
0
0
96
8
134.93
91.05
10.4
3.3
—
—
—
0
0
65
31
22.61
87.41
1.8
2.3
290.7
665.5
e6/l
1.25
18
15
84
70
13.20
85.17
3.1
1.5
—
—
—
0
0
84
70
13.20
85.17
3.1
1.5
—
—
—
0
0
84
70
13.20
85.17
3.1
1.5
—
—
—
0
0
64
34
20.26
82.13
3.6
1.7
—
—
—
0
0
63
33
20.53
81.34
3.5
1.7
—
—
—
0
0
63
33
20.53
81.34
1.3
1.1
—
—
—
0
0
63
33
20.53
81.34
3.5
1.7
—
—
—
0
0
181
395
5.54
81.16
2.5
1.7
1.4
1.6
g/l
0.83
165
347
67
41
17.64
80.45
3.4
1.6
—
—
—
0
0
67
41
17.64
80.45
3.4
1.6
—
—
—
0
0
67
41
17.64
80.45
3.4
1.6
—
—
—
0
0
67
41
17.64
80.45
3.4
1.6
—
—
—
0
0
82
79
11.37
75.60
3.8
2.7
—
—
—
0
0
78
5
171.36
75.39
5.2
1.4
—
—
—
0
0
44
10
46.33
74.24
2.1
1.3
—
—
—
0
0
576
3056
3.71
72.23
18.7
5.6
28.2
25.9
%
4.42
556
2795
343
1328
3.64
70.79
3.3
1.8
—
—
—
0
0
566
3003
3.61
70.24
17.8
5.3
54.7
58.7
%
10.74
544
2769
80
85
10.28
68.78
3.7
3.8
60.1
54.2
%
0.93
56
61
133
262
5.83
66.11
2.0
1.3
—
—
—
0
0
226
693
4.07
65.18
10.1
6.2
13.2
11.3
mmol/l
2.30
214
654
71
73
10.52
62.39
1.5
1.1
210.4
328.6
u/ml
1.25
39
39
58
50
12.37
57.26
1.2
1.0
—
—
—
0
0
295
1172
3.31
56.39
3.7
1.8
28.8
29.9
s
2.60
283
1125
54
45
12.74
54.41
1.3
1.3
—
—
—
0
0
54
45
12.74
54.41
1.3
1.3
—
—
—
0
0
600
3697
3.08
50.34
43.0
6.4
1.2
1.2
mmol/l
0.65
538
3108
257
1044
3.09
46.03
3.5
2.4
24.1
21.9
%
1.78
221
879
593
3732
2.92
45.90
50.3
8.3
3.0
4.3
e9/l
52.30
552
3237
539
3232
2.80
45.76
17.2
4.5
32.9
34.4
g/l
7.56
513
2971
38
24
16.52
44.56
1.2
1.2
—
—
—
0
0
555
3406
2.79
44.53
33.6
5.6
1.2
1.2
mmol/l
0.17
535
3037
262
1101
2.99
43.92
3.4
2.4
2.1
2.3
g/l
4.36
248
1007
49
49
10.55
43.71
1.1
1.2
—
—
—
0
0
235
940
3.07
42.89
2.6
1.7
—
—
—
0
0
235
942
3.06
42.71
2.7
1.8
—
—
—
0
0
42
37
11.89
40.73
2.9
1.3
—
—
—
0
0
42
37
11.89
40.73
3.5
3.4
—
—
—
0
0
42
37
11.89
40.73
2.9
1.3
—
—
—
0
0
268
1188
2.83
40.21
3.4
2.4
12.7
12.2
umol/l
0.53
255
1085
65
104
6.68
39.45
1.7
1.6
—
—
—
0
0
45
49
9.64
37.71
2.7
1.3
—
—
—
0
0
45
49
9.64
37.71
2.7
1.3
—
—
—
0
0
565
3701
2.55
36.36
19.7
5.9
10.1
12.3
umol/l
6.05
555
3487
166
596
3.21
35.94
3.6
3.6
99.0
92.4
ng/l
0.31
150
514
41
42
10.20
35.89
3.2
1.5
—
—
—
0
0
196
779
2.97
35.53
8.5
2.5
4.8
9.7
umol/l
6.46
180
692
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
102
278
4.03
33.49
3.2
2.4
0.3
0.4
u/ml
1.25
62
160
73
159
4.93
31.86
2.3
1.4
—
—
—
0
0
72
155
4.98
31.86
5.0
1.8
93.7
86.5
%
1.83
72
146
104
313
3.64
29.52
4.4
1.9
—
—
—
0
0
34
37
9.53
28.43
1.1
1.3
—
—
—
0
0
73
175
4.47
28.30
1.5
1.3
—
—
—
0
0
73
175
4.47
28.30
1.5
1.3
—
—
—
0
0
308
1682
2.30
27.98
7.0
2.5
—
—
—
0
0
51
91
5.90
27.69
2.7
1.5
—
—
—
0
0
51
91
5.90
27.69
2.7
1.5
—
—
—
0
0
51
91
5.90
27.69
2.6
1.5
—
—
—
0
0
51
91
5.90
27.69
2.6
1.5
—
—
—
0
0
51
92
5.83
27.38
2.6
1.5
—
—
—
0
0
50
89
5.90
27.21
2.7
1.5
—
—
—
0
0
478
3161
2.16
26.46
11.7
4.2
—
—
—
0
0
47
82
6.01
26.10
1.7
1.7
—
—
—
0
0
20
10
20.45
25.85
1.4
1.2
—
—
—
0
0
400
2495
2.13
25.48
9.3
3.4
2.3
2.3
mmol/l
4.60
367
2113
105
357
3.21
24.48
2.5
1.8
2.3
2.2
ug/l
0.04
93
304
28
30
9.62
23.63
1.6
2.1
—
—
—
0
0
52
111
4.92
23.18
1.8
1.5
—
—
—
0
0
55
125
4.63
22.75
1.8
1.5
—
—
—
0
0
49
101
5.09
22.74
4.7
6.2
9.4
12.4
mg/l
4.05
42
92
26
29
9.22
21.28
1.7
1.9
24.6
18.1
%
0.57
12
13
47
99
4.97
21.27
1.6
1.5
—
—
—
0
0
37
65
5.90
20.38
1.4
1.6
—
—
—
0
0
159
748
2.38
19.61
6.8
3.3
1.1
2.1
mmol/l
2.03
124
583
402
2698
1.92
19.16
3.8
2.7
312.8
154.8
ug/l
5.11
372
2408
86
302
3.05
18.88
6.7
4.5
24.1
25.1
mmol/l
2.15
78
282
116
480
2.64
18.75
1.7
1.5
—
—
—
0
0
82
285
3.08
18.32
2.8
1.8
—
—
—
0
0
318
2002
1.94
18.13
2.1
2.2
2.8
3.2
mg/l
1.93
261
1660
18
15
12.24
17.85
3.0
1.9
—
—
—
0
0
114
482
2.57
17.60
5.8
4.0
0.5
2.1
mmol/l
3.58
87
368
22
7
32.20
17.09
1.3
1.0
—
—
—
0
0
508
6263
0.54
16.86
4.0
5.4
2.5
2.6
mmol/l
0.80
461
5590
551
4209
1.87
16.51
17.9
4.7
6.5
6.9
mmol/l
4.02
536
3970
117
517
2.46
16.43
5.9
3.9
4.7
5.2
kpa
7.27
107
474
43
108
4.14
15.66
3.0
2.1
34.3
32.3
pg
2.83
43
108
19
22
8.81
15.06
1.1
1.1
—
—
—
0
0
499
6084
0.57
13.98
3.7
4.8
4.3
4.4
mmol/l
1.48
460
5466
267
1704
1.82
13.85
2.0
1.8
986.9
1183.5
nmol/l
2.66
229
1256
492
6016
0.57
13.84
3.7
4.7
1.3
1.5
mmol/l
9.16
450
5353
17
19
9.11
13.81
1.0
1.1
—
—
—
0
0
372
2620
1.74
13.73
5.3
3.1
2299.7
1821.4
ng/l
1.22
342
2279
108
506
2.30
13.21
2.3
1.7
—
—
—
0
0
20
29
7.04
13.18
1.2
1.2
—
—
—
0
0
232
1442
1.84
12.99
2.9
1.6
1.4
1.3
mg/l
0.17
191
1140
31
70
4.56
12.93
1.2
1.4
265.6
211.4
miu/ml
0.25
11
28
17
21
8.24
12.79
1.1
1.2
—
—
—
0
0
521
6195
0.59
11.77
5.1
5.1
6.0
6.1
mmol/l
0.89
469
5476
233
1491
1.77
11.66
6.7
4.0
156.8
267.9
ng/l
0.66
206
1288
83
1671
0.44
11.57
1.5
1.6
1.5
1.3
mmol/l
1.74
77
1361
370
2699
1.65
11.35
4.2
3.4
—
—
—
0
0
501
5995
0.60
11.29
5.1
6.7
40.4
41.1
mmol/mol
1.19
462
5418
18
28
6.55
11.12
1.9
1.6
755.1
1022.7
u/ml
0.70
18
28
36
103
3.60
10.97
1.5
1.5
—
—
—
0
0
321
2278
1.65
10.84
4.4
3.5
54.8
110.4
e6/l
0.65
272
1810
27
63
4.39
10.83
1.2
1.1
—
—
—
0
0
34
97
3.61
10.41
1.1
1.1
—
—
—
0
0
132
741
1.92
9.93
4.0
3.1
259.0
254.8
ng/l
0.03
119
681
190
1208
1.74
9.50
3.7
3.2
2.1
2.2
e6/l
0.11
105
712
491
5822
0.63
9.48
3.9
4.2
1.4
1.3
mmol/l
2.98
446
5128
225
1504
1.67
9.34
6.7
3.2
2.5
2.5
mmol/l
0.46
203
1301
275
1939
1.62
9.22
1.9
1.6
19.0
20.6
nmol/l
0.94
264
1608
235
1630
1.61
8.29
3.2
2.7
7.0
4.8
e6/l
2.19
217
1438
285
2072
1.56
8.21
4.4
3.4
0.6
0.5
e6/l
0.11
238
1617
44
172
2.64
7.96
2.7
2.8
1.9
1.8
mg/l
0.20
37
151
45
182
2.55
7.61
1.7
1.3
0.2
0.2
g/l
0.08
40
174
15
29
5.25
7.47
1.1
1.2
—
—
—
0
0
46
190
2.50
7.46
1.7
1.3
1.1
1.2
g/l
0.33
41
181
188
1266
1.62
7.39
3.5
3.0
0.8
1.5
e6/l
1.26
104
762
31
106
3.00
7.18
1.3
1.3
—
—
—
0
0
57
264
2.24
7.17
1.2
2.0
33.8
38.6
u/l
0.93
50
228
10
13
7.77
7.13
1.8
1.4
—
—
—
0
0
10
14
7.22
6.71
1.1
1.0
866.3
1412.2
miu/ml
—
10
14
147
956
1.65
6.59
6.7
6.6
1.1
1.4
mmol/l
0.25
108
727
14
29
4.89
6.47
1.1
1.3
—
—
—
0
0
31
113
2.81
6.44
7.2
2.9
2.7
4.7
e9/l
6.02
31
113
266
1990
1.49
6.41
6.6
3.0
31.2
34.7
u/l
0.98
254
1880
32
119
2.75
6.40
7.4
3.3
51.7
61.2
%
2.84
32
119
597
5214
1.48
6.31
34.6
7.4
74.3
81.0
u/l
2.97
583
4831
145
955
1.62
6.17
6.8
6.5
4.9
5.1
kpa
1.16
133
909
145
956
1.62
6.14
6.7
6.5
11.5
11.7
kpa
0.20
134
910
14
31
4.57
6.00
9.3
2.8
206.1
221.6
u/l
0.53
14
31
520
5903
0.70
5.98
50.4
16.6
66.3
72.0
ml/min/173m2
5.34
458
4893
624
6846
0.67
5.87
83.9
25.6
115.1
132.3
g/l
105.72
608
6680
624
6846
0.67
5.87
83.5
25.5
3.7
4.4
e12/l
123.73
603
6593
624
6845
0.67
5.85
83.6
25.5
186.9
239.7
e9/l
55.23
605
6616
507
5771
0.70
5.82
4.6
4.7
2.2
2.0
mu/l
0.91
474
5088
390
3180
1.42
5.80
2.7
2.1
86.5
94.1
pmol/l
3.03
280
1620
283
2182
1.44
5.72
2.8
2.4
55.6
56.9
u/l
0.24
267
2003
58
298
2.02
5.64
2.4
2.8
—
—
—
0
0
11
21
5.29
5.53
1.3
1.2
—
—
—
0
0
119
777
1.62
5.22
7.6
7.2
104.4
120.1
g/l
14.46
113
753
15
40
3.80
5.10
1.4
1.2
44.9
22.8
u/l
0.72
15
33
9
9
10.09
5.03
11.1
12.1
5.2
6.4
mmol/l
—
9
9
363
2984
1.38
4.89
5.5
4.2
43.7
53.3
ng/l
0.40
316
2309
608
6647
0.71
4.87
42.2
11.1
26.0
24.3
u/l
1.27
594
6325
333
2703
1.38
4.83
2.6
2.2
81.8
79.3
nmol/l
0.91
312
2323
15
42
3.62
4.78
1.4
1.2
132.7
83.6
u/l
0.61
15
36
8
8
10.08
4.52
1.1
2.8
—
—
—
0
0
8
8
10.08
4.52
1.0
1.0
—
—
—
0
0
19
66
2.92
4.35
1.5
1.7
—
—
—
0
0
15
46
3.30
4.20
1.0
1.2
—
104.0
—
0
10
620
6708
0.73
4.09
66.4
21.0
4.0
4.0
mmol/l
3.28
607
6489
619
6695
0.73
4.03
58.3
20.9
138.7
139.6
mmol/l
12.26
606
6482
7
7
10.07
4.01
2.4
1.4
—
—
—
0
0
21
81
2.63
4.00
1.1
1.5
—
—
—
0
0
547
4876
1.34
3.98
8.2
4.2
38.1
14.7
mm/h
41.56
519
4413
39
199
2.01
3.93
1.4
1.4
233.7
265.9
ug/g
0.50
25
115
69
422
1.69
3.92
7.1
8.9
23.4
24.6
mmol/l
1.39
63
388
521
4620
1.33
3.88
6.1
5.1
21.2
3392.3
e6/l
—
9
85
59
347
1.75
3.86
8.2
4.2
1.6
1.6
%
0.05
53
327
33
161
2.09
3.75
1.4
2.3
30.7
34.7
umol/l
0.49
23
128
61
367
1.71
3.69
1.9
2.6
—
15.3
—
0
10
6
6
10.06
3.50
2.2
2.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
31
3.58
3.49
1.0
1.2
—
—
—
0
0
7
10
7.05
3.37
1.1
1.0
—
—
—
0
0
187
2355
0.74
3.36
3.2
4.0
21.5
8.8
mg/mmol
2.12
140
1499
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
7
11
6.41
3.19
1.3
2.5
228.4
171.8
%
—
7
11
342
2917
1.29
3.18
3.3
2.3
—
—
—
0
0
93
644
1.50
3.18
2.7
2.3
36.7
35.9
u/l
0.06
80
532
10
29
3.48
3.05
1.0
1.1
—
—
—
0
0
9
21
4.32
3.00
1.3
1.7
44.7
57.1
ug/l
—
9
21
35
194
1.84
2.84
1.2
1.2
—
—
—
0
0
122
1602
0.72
2.82
2.8
3.3
0.9
0.8
ug/l
0.33
94
1136
8
19
4.24
2.68
1.5
1.3
—
—
—
0
0
19
86
2.24
2.65
2.8
3.7
—
—
—
0
0
63
922
0.66
2.64
16.3
8.7
—
—
—
0
0
24
120
2.03
2.63
1.0
1.1
—
—
—
0
0
58
380
1.56
2.58
4.1
2.3
0.6
0.7
%
0.14
58
367
34
193
1.79
2.58
1.2
1.2
—
—
—
0
0
183
2236
0.77
2.55
2.8
3.1
6.7
7.1
mmol/l
0.69
162
1817
10
33
3.05
2.53
1.1
1.1
—
—
—
0
0
30
165
1.85
2.52
1.4
1.5
—
—
—
0
0
10
34
2.96
2.42
1.1
1.0
—
—
—
0
0
6
12
5.03
2.40
1.0
1.1
—
—
—
0
0
7
18
3.91
2.25
2.0
1.4
—
—
—
0
0
5
151
0.33
2.16
1.0
1.3
—
—
—
0
0
7
19
3.71
2.15
1.0
1.3
97.0
101.9
%
—
7
19
75
542
1.42
2.12
7.0
5.9
24.0
24.3
mmol/l
0.27
69
510
22
117
1.90
2.07
1.2
1.3
—
—
—
0
0
8
26
3.10
2.01
1.0
1.3
—
—
—
0
0
189
2240
0.80
1.99
3.8
4.7
20.9
21.4
%
0.21
94
1168
38
241
1.60
1.99
1.2
1.3
—
—
—
0
0
22
119
1.87
1.98
1.4
1.3
1350.2
1393.4
e6/l
0.03
16
82
243
2799
0.82
1.95
3.9
5.5
2.4
3.3
ug/l
1.37
207
2457
6
16
3.77
1.93
1.0
1.1
—
—
—
0
0
6
16
3.77
1.93
1.0
1.1
—
—
—
0
0
36
227
1.61
1.93
3.2
3.2
23.7
24.9
mmol/l
0.94
30
191
6
17
3.55
1.84
1.0
1.1
—
—
—
0
0
6
17
3.55
1.84
1.0
1.1
—
—
—
0
0
6
17
3.55
1.84
1.0
1.1
—
—
—
0
0
5
12
4.18
1.82
1.0
1.2
—
—
—
0
0
138
1674
0.79
1.77
1.6
1.8
457.1
12528563.0
pmol/l
1.08
117
1333
14
68
2.08
1.71
2.1
2.3
0.2
2.1
u/field
—
5
24
151
1802
0.80
1.67
4.6
4.4
0.0
0.0
estimate
0.00
38
566
67
497
1.38
1.67
7.2
8.4
0.8
0.7
%
0.42
67
491
105
843
1.28
1.54
2.1
4.0
4.5
30.3
ug/l
1.83
84
716
58
428
1.38
1.51
2.7
2.9
0.3
0.3
e6/l
0.09
58
421
11
51
2.17
1.51
1.5
1.5
—
—
—
0
0
8
168
0.47
1.48
1.1
1.4
—
—
—
0
0
66
502
1.34
1.43
7.2
8.2
1.3
1.4
%
0.52
66
496
441
4732
0.86
1.42
3.8
3.8
14.6
15.1
pmol/l
3.39
416
4152
9
40
2.26
1.40
1.6
1.7
—
—
—
0
0
9
41
2.21
1.37
1.6
1.7
—
—
—
0
0
6
23
2.62
1.37
1.2
2.2
—
—
—
0
0
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
0
38
0.00
1.34
0.0
1.6
—
—
—
0
0
34
237
1.45
1.24
2.7
3.1
0.8
0.9
nmol/l
0.51
25
188
137
1164
1.21
1.23
26.2
29.2
1.3
1.4
inr
0.18
22
148
27
180
1.52
1.22
1.3
1.5
0.1
26.8
iu/ml
—
8
45
223
2483
0.86
1.13
4.5
4.5
—
—
—
0
0
78
631
1.26
1.12
1.4
1.3
—
—
—
0
0
5
21
2.39
1.09
1.0
1.2
—
—
—
0
0
251
2271
1.15
1.07
2.5
2.2
163.3
248.8
u/l
1.15
237
2120
5
22
2.28
1.03
1.0
1.0
—
—
—
0
0
26
180
1.46
1.01
1.2
1.9
—
—
—
0
0
44
570
0.76
1.00
1.3
1.4
—
—
—
0
0
26
181
1.45
0.99
1.8
1.7
22005.2
18195.3
e6/l
0.17
18
132
17
260
0.65
0.99
1.9
1.8
—
—
—
0
0
17
108
1.59
0.97
1.4
1.3
16459.9
87606.7
e6/l
—
8
63
88
736
1.22
0.96
2.4
2.6
6.4
6.2
ug/l
0.03
72
633
38
498
0.75
0.94
1.3
1.7
1.5
1.6
%
0.89
29
409
14
86
1.64
0.91
1.9
1.6
—
—
—
0
0
6
33
1.82
0.79
3.0
4.6
—
—
—
0
0
0
26
0.00
0.78
0.0
1.5
—
—
—
0
0
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
23
166
1.40
0.76
1.4
1.3
—
—
—
0
0
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
11
69
1.60
0.68
1.1
1.1
—
—
—
0
0
9
59
1.53
0.68
1.0
1.1
—
—
—
0
0
27
205
1.33
0.68
1.4
1.4
—
—
—
0
0
15
103
1.46
0.65
1.6
1.9
87.8
89.2
%
0.25
15
103
480
4985
0.92
0.63
74.3
21.3
15.3
13.9
%
48.99
469
4864
524
5420
0.91
0.62
61.6
19.0
34.2
38.4
%
14.90
333
3283
18
130
1.39
0.61
1.0
1.2
13.2
36.2
e6/l
0.42
13
100
18
130
1.39
0.61
1.1
1.3
17.1
1055.9
e6/l
0.65
13
103
8
53
1.51
0.58
1.0
1.2
—
81.8
—
0
6
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
22
170
1.30
0.52
3.0
2.6
13.4
15.5
%
—
10
85
338
3222
1.08
0.52
5.5
5.6
0.0
0.0
estimate
0.00
52
594
12
84
1.43
0.49
1.3
1.5
68.7
69.0
%
—
6
58
342
3268
1.08
0.49
3.9
4.2
0.0
0.0
estimate
0.50
51
579
338
3230
1.08
0.48
3.9
4.1
0.0
0.0
estimate
0.00
53
602
135
1463
0.91
0.46
4.3
4.6
1.0
1.0
kg/l
0.95
25
223
5
32
1.57
0.42
1.2
1.0
305.4
308.2
mg/l
—
5
27
8
58
1.38
0.41
1.1
1.5
—
352.2
—
0
9
14
105
1.34
0.41
1.6
2.5
27.2
26.5
mg/l
—
5
25
0
18
0.00
0.40
0.0
1.2
—
10.0
—
0
18
23
281
0.81
0.40
1.0
1.2
169.8
127.3
iu/ml
—
10
103
0
19
0.00
0.39
0.0
2.1
—
2.3
—
0
7
8
113
0.71
0.37
1.0
1.1
—
—
—
0
0
19
152
1.26
0.37
1.7
1.6
—
—
—
0
0
622
6332
0.94
0.37
66.3
17.4
22.2
27.4
mg/l
4.40
592
5198
82
899
0.90
0.36
3.2
4.8
31.7
32.7
%
0.28
59
566
37
319
1.17
0.36
1.9
3.2
14.6
12771.4
u/ml
0.83
31
268
5
78
0.64
0.35
1.2
1.0
—
—
—
0
0
6
45
1.34
0.34
1.0
1.0
—
—
—
0
0
83
898
0.92
0.30
1.2
1.2
11.3
12.3
u/ml
0.03
13
301
8
109
0.73
0.29
1.1
1.3
—
—
—
0
0
20
167
1.20
0.28
2.8
2.4
106.8
126.4
g/l
2.57
14
122
8
63
1.27
0.28
1.0
1.1
—
—
—
0
0
20
236
0.84
0.27
1.1
1.0
—
—
—
0
0
15
123
1.22
0.25
1.2
1.5
2.2
6.7
iu/l
—
5
30
20
170
1.18
0.24
2.6
4.0
22.2
28.7
mg/l
0.72
14
111
5
38
1.32
0.23
1.0
1.3
—
—
—
0
0
5
38
1.32
0.23
1.0
1.3
—
—
—
0
0
5
39
1.28
0.23
3.8
2.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
28
314
0.89
0.21
2.0
3.3
1.5
1.4
mmol/l
0.15
28
307
11
91
1.21
0.17
1.6
1.9
182.6
212.4
pmol/l
0.31
11
82
7
63
1.11
0.17
1.0
1.6
—
21.5
—
0
11
371
3778
0.97
0.17
3.6
3.1
67.7
54.5
u/l
1.63
355
3427
119
1146
1.04
0.15
1.2
1.2
1.9
1.5
u/ml
—
5
283
91
944
0.96
0.12
1.2
1.3
35.3
38.3
iu/ml
0.05
27
307
226
2215
1.03
0.11
9.8
3.2
10779.1
281.2
mg/l
13.56
183
1427
50
525
0.95
0.10
5.0
3.1
55.1
56.7
ml/min/173m2
0.10
28
220
5
48
1.04
0.09
2.8
2.5
—
—
—
0
0
12
132
0.91
0.06
1.1
1.2
—
—
—
0
0
21
197
1.07
0.06
1.1
1.4
—
—
—
0
0
83
811
1.03
0.06
5.1
3.7
—
—
—
0
0
10
109
0.92
0.04
1.3
1.2
—
35.5
—
0
9
13
137
0.95
0.01
1.4
1.6
—
—
—
0
0
12
126
0.95
0.00
1.0
1.2
—
9.5
—
0
11
14
146
0.96
0.00
1.3
1.2
—
2.8
—
0
18
22
225
0.98
0.00
1.5
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
12.1
—
0
8
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
6
68
0.88
0.00
1.3
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
2.6
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
535.6
—
0
5
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MULT_MYELOMA – Multiple myeloma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).